Adaptimmune - ADR (ADAP) Stock Price Today, Chart, Quote and News | baraka

A

Adaptimmune - ADR (ADAP)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Adaptimmune - ADR (ADAP)

Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform. Its SPEAR T-cell platform enables it... Read more

Open
USD1.05
High
USD1.07
Low
USD1.05
52 Week High
USD2.05
Monthly Return
-25.00%
Revenue
48M

Daily Vol.
47.10k
Avg. Daily Vol.
1.36M
Market Cap.
250M
52 Week Low
0.42
Annual Return
-21.70%

Stock News

Vivid Seats Renews National Make-A-Wish® Partnership to Grant Live Event Experiences

Vivid Seats Renews National Make-A-Wish® Partnership to Grant Live Event Experiences

Yahoo

Partner base continues to grow: Greenman Energy opts for battery-buffered fast chargers from ADS-TEC Energy

Partner base continues to grow: Greenman Energy opts for battery-buffered fast chargers from ADS-TEC Energy

Yahoo

Redfin Reports Home Prices Stagnate in Florida and Texas as Supply Soars

Redfin Reports Home Prices Stagnate in Florida and Texas as Supply Soars

Yahoo

Leading Office Furniture Manufacturer Implements Bridgeline’s HawkSearch

Leading Office Furniture Manufacturer Implements Bridgeline’s HawkSearch

Yahoo

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.